Utilization of Inferiorly Based Dermofat Flap in Breast Reconstruction after Simple Mastectomy due to Gigantomastia

Gigantomastia (GM) is a rare disabling condition characterized by excessive breast tissue growth. To date, there is no universal classification and definition of GM. At present, GM is determined as weight over 1.5 kg per breast (Dancey et al., 2008) or 3% or more of the patient’s total body weight (...

Full description

Bibliographic Details
Main Authors: A. Bogdanov-Berezovsky, Y. Krieger, Y. Shoham, E. Silberstein
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Case Reports in Surgery
Online Access:http://dx.doi.org/10.1155/2013/248969
id doaj-d5ec10c297a643618406e30a73d36e99
record_format Article
spelling doaj-d5ec10c297a643618406e30a73d36e992020-11-24T22:16:27ZengHindawi LimitedCase Reports in Surgery2090-69002090-69192013-01-01201310.1155/2013/248969248969Utilization of Inferiorly Based Dermofat Flap in Breast Reconstruction after Simple Mastectomy due to GigantomastiaA. Bogdanov-Berezovsky0Y. Krieger1Y. Shoham2E. Silberstein3Department of Plastic and Reconstructive Surgery and Burn Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101 Beer-Sheva, IsraelDepartment of Plastic and Reconstructive Surgery and Burn Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101 Beer-Sheva, IsraelDepartment of Plastic and Reconstructive Surgery and Burn Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101 Beer-Sheva, IsraelDepartment of Plastic and Reconstructive Surgery and Burn Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101 Beer-Sheva, IsraelGigantomastia (GM) is a rare disabling condition characterized by excessive breast tissue growth. To date, there is no universal classification and definition of GM. At present, GM is determined as weight over 1.5 kg per breast (Dancey et al., 2008) or 3% or more of the patient’s total body weight (Dafydd et al., 2011). The lack of generally acknowledged approach regarding GM is expressed by the different methods of its treatment ranging from hormonal prescription to mastectomy and subsequent complex breast reconstruction (Shoma et al., 2011). We describe a treatment approach, including simple mastectomy and immediate breast reconstruction by an inferiorly based dermofat flap with silicone implants and nipple grafting.http://dx.doi.org/10.1155/2013/248969
collection DOAJ
language English
format Article
sources DOAJ
author A. Bogdanov-Berezovsky
Y. Krieger
Y. Shoham
E. Silberstein
spellingShingle A. Bogdanov-Berezovsky
Y. Krieger
Y. Shoham
E. Silberstein
Utilization of Inferiorly Based Dermofat Flap in Breast Reconstruction after Simple Mastectomy due to Gigantomastia
Case Reports in Surgery
author_facet A. Bogdanov-Berezovsky
Y. Krieger
Y. Shoham
E. Silberstein
author_sort A. Bogdanov-Berezovsky
title Utilization of Inferiorly Based Dermofat Flap in Breast Reconstruction after Simple Mastectomy due to Gigantomastia
title_short Utilization of Inferiorly Based Dermofat Flap in Breast Reconstruction after Simple Mastectomy due to Gigantomastia
title_full Utilization of Inferiorly Based Dermofat Flap in Breast Reconstruction after Simple Mastectomy due to Gigantomastia
title_fullStr Utilization of Inferiorly Based Dermofat Flap in Breast Reconstruction after Simple Mastectomy due to Gigantomastia
title_full_unstemmed Utilization of Inferiorly Based Dermofat Flap in Breast Reconstruction after Simple Mastectomy due to Gigantomastia
title_sort utilization of inferiorly based dermofat flap in breast reconstruction after simple mastectomy due to gigantomastia
publisher Hindawi Limited
series Case Reports in Surgery
issn 2090-6900
2090-6919
publishDate 2013-01-01
description Gigantomastia (GM) is a rare disabling condition characterized by excessive breast tissue growth. To date, there is no universal classification and definition of GM. At present, GM is determined as weight over 1.5 kg per breast (Dancey et al., 2008) or 3% or more of the patient’s total body weight (Dafydd et al., 2011). The lack of generally acknowledged approach regarding GM is expressed by the different methods of its treatment ranging from hormonal prescription to mastectomy and subsequent complex breast reconstruction (Shoma et al., 2011). We describe a treatment approach, including simple mastectomy and immediate breast reconstruction by an inferiorly based dermofat flap with silicone implants and nipple grafting.
url http://dx.doi.org/10.1155/2013/248969
work_keys_str_mv AT abogdanovberezovsky utilizationofinferiorlybaseddermofatflapinbreastreconstructionaftersimplemastectomyduetogigantomastia
AT ykrieger utilizationofinferiorlybaseddermofatflapinbreastreconstructionaftersimplemastectomyduetogigantomastia
AT yshoham utilizationofinferiorlybaseddermofatflapinbreastreconstructionaftersimplemastectomyduetogigantomastia
AT esilberstein utilizationofinferiorlybaseddermofatflapinbreastreconstructionaftersimplemastectomyduetogigantomastia
_version_ 1725789887905398784